Device for the treatment of an ocular disease

US9962287B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9962287-B2
Application numberUS-201214238949-A
CountryUS
Kind codeB2
Filing dateAug 14, 2012
Priority dateAug 16, 2011
Publication dateMay 8, 2018
Grant dateMay 8, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An electrode device having an insertion part ( 12 ) adapted to be inserted into the suprachoroidal space of an eye so as to reach a service position, and an handling part ( 14 ) for manipulation of the electrode device, said electrode device comprising: —a support ( 25 ) having a distal part ( 31 ); —a set of wires ( 20 ) supported by said support and mobile between a retracted position in which said wires substantially extend along the support, and a deployed position in which respective parts of said wires, called “outside parts”, project from said distal part ( 31 ) of the support; —an electrically conductive element forming at least a portion of a said outside part or supported by a said outside part; —an electrical conductor ( 60 ) enabling, in said deployed position, an electrical connection between said electrically conductive element and an electrical generator; and —an actuator ( 16, 60 ) adapted for an operator to move the set of wires from said retracted position to said deployed position in said service position.

First claim

Opening claim text (preview).

The invention claimed is: 1. An electroporation device for the electroporation of a therapeutic nucleic acid after delivering a pharmaceutical composition formulated with said therapeutic nucleic acid into the suprachoroidal space of a diseased eye, comprising: an electrode device having an insertion part conformed to be inserted into said suprachoroidal space of said eye so as to reach a service position located inside said suprachoroidal space, and a handling part for manipulation of the electrode device, said electrode device comprising: a support having a distal part; a set of a plurality of wires supported by said support and mobile between a retracted position in which said plurality of wires substantially extend along the support, and a deployed position in which outside parts which are respected parts of said plurality of wires project from said distal part of the support into said suprachoroidal space, the distal part of the support being conformed to be inserted into said suprachoroidal space in said retracted position, the outside parts of the plurality of wires being configured to be inserted into said suprachoroidal space in said deployed position; at least one electrically conductive element forming at least a portion of said outside parts or supported by said outside parts; —an electrical generator; an electrical conductor enabling, in said deployed position, an electrical connection between said at least one electrically conductive element and the electrical generator; an actuator actuated by an operator to move the plurality of wires from said retracted position to said deployed position in said service position; said insertion part having a distal tip conformed so as to be atraumatic; a surface counter electrode to be applied on an outside surface of the eye; and the electrical generator adapted to polarize differently said at least one electrically conductive element and the counter electrode, and to generate an electrical field enabling electroporation. 2. The electroporation device according to claim 1 , in which a length of said outside parts of the plurality of wires is more than 1 mm and less than 15 mm. 3. The electroporation device according to claim 2 , in which a length of said outside parts is more than 4 mm and less than 8 mm. 4. The electroporation device according to claim 1 , in which said outside parts of the set of a plurality of wires extend, in the deployed position, along a spherical surface, with a radius of curvature greater than 9 mm and less than 15 mm. 5. The electroporation device according to claim 1 , in which each of the outside parts of the plurality of wires comprises the at least one electrically conductive element, the electrical conductor enabling, in said deployed position, an electrical connection between said at least one electrically conductive element and said electrical generator. 6. The electroporation device according to claim 1 , in which the at least one electrically conductive element of the plurality of wires is constituted by the outside parts of the plurality of wires, or by the plurality of wires, and/or by an electrically conductive coating of said outside parts and/or by an electrically conductive web at least partially supported by said outside parts. 7. The electroporation device according to claim 1 , in which the insertion part of the electrode device is curved, a radius of curvature being greater than 9 mm and less than 15 mm. 8. The electroporation device according to claim 1 , in which a width and/or a thickness of the insertion part of the electrode device is less than 2.0 mm. 9. The electroporation device according claim 1 , in which a width and/or a thickness of the insertion part of the electrode device is less than 0.5 mm. 10. The electroporation device according to claim 1 , in which the distal part of the support is provided with a lumen which laterally diverges at an approach of a distal end of the support and opens outwardly at said distal end and/or divides into a plurality of guiding tubes opening outwardly through respective openings, said lumen and said plurality of guiding tubes containing, in the retracted position, one or several of said plurality of wires. 11. The electroporation device according to claim 1 , in which a diameter of each wire of the plurality of wires is less than 0.5 mm. 12. The electroporation device according to claim 1 , which comprises a cable which, in the service position, performs: establishing, at least in the deployed position, an electrically conductive path between the electrical generator and the at least one electrically conductive element; and/or establishing a mechanical relationship between the set of a plurality of wires and the outside surface of the eye so that an operator may move said set of a plurality of wires from the retracted position to the deployed position. 13. The electroporation device according to claim 1 , in which the support is a sleeve, slidably mounted on a cable, so that a pull or a push on the support makes the plurality of wires exit from or enter into the support, and/or in which, in said deployed position, at least one of said plurality of wires projects from said support in a loop shape. 14. A method of treating an ocular disease in a subject in need thereof, comprising: delivering a pharmaceutical composition comprising a therapeutic nucleic acid to a diseased eye; and then transferring said therapeutic nucleic acid into the suprachoroidal space of said diseased eye by electroporation using the electroporation device as claimed in claim 1 . 15. The electroporation device according to claim 1 , wherein the plurality of wires are configured to be atraumatic. 16. The electroporation device according to claim 1 , in which, in the deployed position, the outside parts of the plurality of wires exit laterally and/or axially from respective openings of the support.

Assignees

Inventors

Classifications

  • A61F9/0008Primary

    Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00) · CPC title

  • for enhancing the absorption properties of tissue, e.g. by electroporation · CPC title

  • A61N1/0526Primary

    Head electrodes (A61N1/0551 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9962287B2 cover?
An electrode device having an insertion part ( 12 ) adapted to be inserted into the suprachoroidal space of an eye so as to reach a service position, and an handling part ( 14 ) for manipulation of the electrode device, said electrode device comprising: —a support ( 25 ) having a distal part ( 31 ); —a set of wires ( 20 ) supported by said support and mobile between a retracted position in whic…
Who is the assignee on this patent?
Behar Cohen Francine, Inst Nat Sante Rech Med
What technology area does this patent fall under?
Primary CPC classification A61F9/0008. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).